Bolt Biotherapeutics Stock Performance
| BOLT Stock | USD 4.95 0.03 0.61% |
On a scale of 0 to 100, Bolt Biotherapeutics holds a performance score of 4. The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bolt Biotherapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bolt Biotherapeutics is expected to be smaller as well. Please check Bolt Biotherapeutics' downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Bolt Biotherapeutics' price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bolt Biotherapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent essential indicators, Bolt Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.61 | Five Day Return (13.61) | Year To Date Return (14.51) | Ten Year Return (99.23) | All Time Return (99.23) |
Last Split Factor 1:20 | Last Split Date 2025-06-09 |
1 | Acquisition by Miller Richard A Md of 25000 shares of Bolt Biotherapeutics at 1.63 subject to Rule 16b-3 | 11/25/2025 |
2 | Roamlys Specialty RV Insurance Now Available to Agents on bolts Platform Nationwide | 12/03/2025 |
3 | Acquisition by Onetto Nicole of 25000 shares of Bolt Biotherapeutics subject to Rule 16b-3 | 12/11/2025 |
4 | Disposition of 7614 shares by William Quinn of Bolt Biotherapeutics at 56.0 subject to Rule 16b-3 | 12/12/2025 |
5 | Published on 2025-12-19 092125 - ulpravda.ru | 12/18/2025 |
6 | BOLT SEC Filings - Bolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan | 12/24/2025 |
7 | Street Watch Why Bolt Biotherapeutics Inc. stock could rally in 2025 - Trade Ideas Short-Term Trading Alerts - moha.gov.vn | 01/05/2026 |
8 | Disposition of 1100 shares by Ocallaghan Brian of Bolt Biotherapeutics at 15.364 subject to Rule 16b-3 | 01/16/2026 |
9 | Acquisition by Sarah Nemec of 1589 shares of Bolt Biotherapeutics at 5.44 subject to Rule 16b-3 | 01/27/2026 |
10 | Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn | 02/09/2026 |
| Begin Period Cash Flow | 12.6 M | |
| Total Cashflows From Investing Activities | 57.6 M |
Bolt Biotherapeutics Relative Risk vs. Return Landscape
If you would invest 451.00 in Bolt Biotherapeutics on November 17, 2025 and sell it today you would earn a total of 44.00 from holding Bolt Biotherapeutics or generate 9.76% return on investment over 90 days. Bolt Biotherapeutics is currently generating 0.2384% in daily expected returns and assumes 4.2375% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Bolt, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bolt Biotherapeutics Target Price Odds to finish over Current Price
The tendency of Bolt Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.95 | 90 days | 4.95 | about 82.07 |
Based on a normal probability distribution, the odds of Bolt Biotherapeutics to move above the current price in 90 days from now is about 82.07 (This Bolt Biotherapeutics probability density function shows the probability of Bolt Stock to fall within a particular range of prices over 90 days) .
Bolt Biotherapeutics Price Density |
| Price |
Predictive Modules for Bolt Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bolt Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bolt Biotherapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bolt Biotherapeutics is not an exception. The market had few large corrections towards the Bolt Biotherapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bolt Biotherapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bolt Biotherapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.47 | |
σ | Overall volatility | 0.61 | |
Ir | Information ratio | 0.01 |
Bolt Biotherapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bolt Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bolt Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bolt Biotherapeutics had very high historical volatility over the last 90 days | |
| Bolt Biotherapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.69 M. Net Loss for the year was (63.12 M) with loss before overhead, payroll, taxes, and interest of (30.07 M). | |
| Bolt Biotherapeutics currently holds about 176.34 M in cash with (61.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.68. | |
| Latest headline from news.google.com: Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn |
Bolt Biotherapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bolt Stock often depends not only on the future outlook of the current and potential Bolt Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bolt Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.2 M | |
| Cash And Short Term Investments | 47.3 M |
Bolt Biotherapeutics Fundamentals Growth
Bolt Stock prices reflect investors' perceptions of the future prospects and financial health of Bolt Biotherapeutics, and Bolt Biotherapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bolt Stock performance.
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (3.55) % | ||||
| Current Valuation | 1.18 M | ||||
| Shares Outstanding | 1.92 M | ||||
| Price To Earning | 36.55 X | ||||
| Price To Book | 0.30 X | ||||
| Price To Sales | 1.83 X | ||||
| Revenue | 7.69 M | ||||
| Gross Profit | (30.07 M) | ||||
| EBITDA | (66.45 M) | ||||
| Net Income | (63.12 M) | ||||
| Cash And Equivalents | 176.34 M | ||||
| Cash Per Share | 4.68 X | ||||
| Total Debt | 25.21 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 9.73 X | ||||
| Book Value Per Share | 16.72 X | ||||
| Cash Flow From Operations | (61.29 M) | ||||
| Earnings Per Share | (22.21) X | ||||
| Market Capitalization | 9.5 M | ||||
| Total Asset | 99.63 M | ||||
| Retained Earnings | (427.4 M) | ||||
| Working Capital | 34.96 M | ||||
| Current Asset | 53.49 M | ||||
| Current Liabilities | 9.12 M | ||||
About Bolt Biotherapeutics Performance
Assessing Bolt Biotherapeutics' fundamental ratios provides investors with valuable insights into Bolt Biotherapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bolt Biotherapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.57) | (0.60) | |
| Return On Capital Employed | (0.78) | (0.82) | |
| Return On Assets | (0.57) | (0.60) | |
| Return On Equity | (1.27) | (1.21) |
Things to note about Bolt Biotherapeutics performance evaluation
Checking the ongoing alerts about Bolt Biotherapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bolt Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bolt Biotherapeutics had very high historical volatility over the last 90 days | |
| Bolt Biotherapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.69 M. Net Loss for the year was (63.12 M) with loss before overhead, payroll, taxes, and interest of (30.07 M). | |
| Bolt Biotherapeutics currently holds about 176.34 M in cash with (61.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.68. | |
| Latest headline from news.google.com: Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn |
- Analyzing Bolt Biotherapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bolt Biotherapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Bolt Biotherapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bolt Biotherapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bolt Biotherapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bolt Biotherapeutics' stock. These opinions can provide insight into Bolt Biotherapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.